Biocon Biologics Uk Plc
Clinical trials sponsored by Biocon Biologics Uk Plc, explained in plain language.
-
New cheaper version of melanoma drug enters testing
Disease control Not yet recruitingThis study aims to see if a new, potentially more affordable version of the cancer drug Opdivo (called Bmab1700) behaves similarly in the body. It will involve 120 adults whose melanoma has been completely removed by surgery. Participants will receive either the new drug or Opdiv…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New cancer drug copycat tested on healthy volunteers
Knowledge-focused Not yet recruitingThis is an early, first-in-human study to see how a new, similar version of the cancer drug Herceptin Hylecta (called Bmab3000) behaves in the body. It will involve 150 healthy male volunteers who will receive a single injection and be monitored for about four months. The main go…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:26 UTC